Intra-Cellular Therapies SG&A Expenses 2013-2024 | ITCI
- Intra-Cellular Therapies annual sg&a expenses for 2024 were $0.504B, a 0% decline from 2024.
- Intra-Cellular Therapies annual sg&a expenses for 2024 were $0.504B, a 23.09% increase from 2023.
- Intra-Cellular Therapies annual sg&a expenses for 2023 were $0.41B, a 0% decline from 2023.